Short Versus Long Duration of DAPT After DES Implantation: A Meta-Analysis
Author:
Publisher
Elsevier BV
Subject
Cardiology and Cardiovascular Medicine
Reference5 articles.
1. 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions;Levine;J Am Coll Cardiol,2011
2. Six-month versus 12-month dual antiplatelet therapy after implantation of drug-eluting stents: the Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting (EXCELLENT) randomized, multicenter study;Gwon;Circulation,2012
3. Short- versus long-term duration of dual-antiplatelet therapy after coronary stenting: a randomized multicenter trial;Valgimigli;Circulation,2012
4. A new strategy for discontinuation of dual antiplatelet therapy: the RESET Trial (REal Safety and Efficacy of 3-month dual antiplatelet Therapy following Endeavor zotarolimus-eluting stent implantation);Kim;J Am Coll Cardiol,2012
5. Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the OPTIMIZE randomized trial;Feres;JAMA,2013
Cited by 30 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Five-Year Impacts of Antithrombotic Therapy Based on 10-Year Clinical Outcomes of Cypher™ Stent Implantation;Cardiology and Therapy;2022-06-21
2. International Perspectives on the Impact of the COVID-19 Pandemic on Adherence to Prescribed Dual Antiplatelet Therapy: A Window Into Acute Cardiovascular Care;Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine;2022-06-17
3. Extended, standard, or De-escalation antiplatelet therapy for patients with coronary artery disease undergoing percutaneous coronary intervention? A trial-sequential, bivariate, influential, and network meta-analysis;European Heart Journal - Cardiovascular Pharmacotherapy;2022-03-24
4. Adherence and persistence analysis in patients treated with double antiplatelet therapy (DAPT) at two years in real life;Patient Education and Counseling;2021-08
5. Endovascular drug-delivery and drug-elution systems;Biomechanics of Coronary Atherosclerotic Plaque;2021
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3